Strategic Elements Competitors

Mineral Resources Limited (MinRes) is a leading diversified resources company, with extensive operations in lithium, iron ore, energy and mining services across Western Australia.

Agriculture is evolving and so is Nufarm. Nufarm is a global crop protection and seed technologies company that helps farmers and businesses meet the global needs of food, feed, fibre and fuel production. We bring our proven agility, capabilities and partnerships to help our customers in a rapidly changing world. Our 3000+ team, deep agricultural science expertise, and dynamic culture across nearly 50 countries mean that we can manoeuvre quickly into areas where technologies and opportunities converge, adding real value for people and the planet. We proudly join forces with universities, suppliers and innovation partners worldwide to collaborate, develop and deliver sustainable solutions that rapidly respond to the evolving needs of existing and new customers. Nufarm is listed on the Australian Securities Exchange (ASX:NUF) and our head office is in Melbourne, Australia. Nufarm. Evolving Ag.

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVEL’s research and development has led to innovative treatments for patient populations with a clinical need for systemic photoprotection, DNA repair and acute or life threatening conditions. These patient groups range in size from 5,000 to 45 million worldwide. CLINUVEL’s lead compound, SCENESSE® (afamelanotide 16mg), was approved by the European Commission in 2014 and the US Food and Drug Administration in 2019 for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). More information on EPP can be found at http://www.epp.care. Headquartered in Melbourne, Australia, CLINUVEL has operations in Europe, Singapore, and the USA. For more information please go to http://www.clinuvel.com. SCENESSE® and PRÉNUMBRA® are registered trademarks of CLINUVEL PHARMACEUTICALS LTD